CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Category: Business
Global Optic Nerve Injury Drugs Pipeline Report 2021: Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Nerve Injury (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Optic Nerve Injury (Ophthalmology) – Drugs in Development, 2021 provides an overview of the Optic…
Seoul Semiconductor Expands Its Business Through SunLike Natural Sunlight Spectrum LED Technology Patents and Business Rights Transfer
ANSAN, South Korea–(BUSINESS WIRE)– #CircadianRhythmLEDlighting–Seoul Semiconductor acquired all SunLike technology for natural light source jointly developed with Toshiba Materials.
CooperVision est fière de nommer Mitsou comme porte-parole au Québec pour sensibiliser à la myopie chez les enfants
MONTRÉAL–(BUSINESS WIRE)–CooperVision Canada, un chef de file mondial dans la gestion de la myopie, annonce aujourd’hui que la populaire chanteuse pop québécoise, entrepreneure, actrice et animatrice de télévision et de radio, Mitsou Gélinas, comme n…
CooperVision Proudly Names Mitsou as Québec Spokesperson to Raise Awareness Around Myopia in Children
MONTRÉAL–(BUSINESS WIRE)–CooperVision Canada, a global leader in myopia management, today announced that popular Québec pop singer, entrepreneur, actress, television and radio host Mitsou Gélinas has become their new spokesperson for a campaign to ra…
Conjunctivitis (Ophthalmology) Pipeline Landscape Report 2021: Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Conjunctivitis (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Conjunctivitis (Ophthalmology) – Drugs in Development, 2021 provides an overview of the Conjunctiviti…
Glaukos Announces Participation in the Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
EyeSouth Partners Expands Network in South Florida Through Addition of Dr. James Guildford
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce the addition of Dr. James H. Guildford, M.D. based in West Palm Beach, Florida. As part of the addition, Dr. Guildford will join Retina Care Specialists in…
Texan Eye Enters Partnership with Comprehensive EyeCare Partners
LAS VEGAS & AUSTIN, Texas–(BUSINESS WIRE)– #Financials–Comprehensive EyeCare Partners (CompEye), one of the largest vision care practice management organizations in the nation, is pleased to announce a strategic partnership with Texan Eye, a leading…
Visus Therapeutics Appoints Industry Leaders Tracy Valorie and Dwight Moxie to Board of Directors
SEATTLE–(BUSINESS WIRE)–Visus Therapeutics Inc., a clinical-stage pharmaceutical company developing innovative ophthalmic therapies to improve vision for people around the world, today announced the appointments of Tracy Valorie, former Senior Vice P…
Warby Parker Announces Public Filing of Registration Statement for Proposed Direct Listing of its Class A Common Stock
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. today announced that it has publicly filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public listing of its Class A common stock. Th…
Fuchs Endothelial Corneal Dystrophy (Ophthalmology) Pipeline Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fuchs Endothelial Corneal Dystrophy (FECD) (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Fuchs Endothelial Corneal Dystrophy (FECD) (Ophthalmology) – Drugs in Dev…
Global Optic Neuropathy (Ophthalmology) Drugs In Development 2021 Market Report – Featuring Antoxis, Astellas Pharma and Quark Pharmaceuticals – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuropathy (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. Optic …
Oscar Wylee Announces Launch Into Canadian Market
EDMONTON, Alberta–(BUSINESS WIRE)– #Canada–Australian eyewear retailer, Oscar Wylee announces their expansion into Canada, with their first store set to open in West Edmonton Mall, Alberta at the end of August 2021. This comes on the back of the eye…
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
NASHVILLE, Tenn. & TOKYO–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced that it has entered into an agreement with Wakamoto Pharmaceutical Co., Ltd. to acquire the U.S. and Cana…
VerkaziaTM (cyclosporine 0.1%) for the Treatment of Severe Vernal Keratoconjunctivitis is Now Reimbursed by Non-Insured Health Benefits (NIHB) Program
TORONTO–(BUSINESS WIRE)–VerkaziaTM (cyclosporine 0.1%) for the Treatment of Severe Vernal Keratoconjunctivitis is Now Reimbursed by Non-Insured Health Benefits (NIHB) Program
VerkaziaMC (cyclosporine à 0,1 %) est désormais remboursé par le Programme des services de santé non assurés (SSNA) pour traiter la kératoconjonctivite vernale grave
TORONTO–(BUSINESS WIRE)–Santen Canada Inc., filiale de Santen Pharmaceutical Co., Ltd. (« Santen »), société internationale œuvrant exclusivement dans le domaine de l’ophtalmologie, a annoncé aujourd’hui que VerkaziaMC (émulsion ophtalmique topique d…
LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chie…
Global Choroidal Neovascularization (Ophthalmology) Drug Development Market Report 2021: Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Choroidal Neovascularization (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Choroidal Neovascularization (Ophthalmology) – Drugs in Development, 2021 provides an o…
Global Retinopathy (Ophthalmology) Drugs Development Market Report 2021: Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinopathy (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Retinopathy (Ophthalmology) – Drugs in Development, 2021 provides an overview of the Retinopathy pipelin…